These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1829436)

  • 1. [T-helper cell subsets in patients with inflammatory rheumatic diseases undergoing immunosuppressive therapy].
    Becker H; Potyka P; Weber C; Renelt M; Federlin K
    Immun Infekt; 1991 Feb; 19(1):26-7. PubMed ID: 1829436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment of collagen diseases].
    Cruchaud A
    Ther Umsch; 1969 Dec; 26(12):697-702. PubMed ID: 5386688
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive therapy in rheumatic disease.
    Pirofsky B; Bardana EJ
    Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive drugs in rheumatic diseases (author's transl)].
    Gerster JC; Fallet GH
    Ther Umsch; 1979 May; 36(5):443-9. PubMed ID: 451957
    [No Abstract]   [Full Text] [Related]  

  • 9. [DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
    Huber C; Günther R; Michlmayr G; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1973 Feb; 85(6):92-5. PubMed ID: 4155172
    [No Abstract]   [Full Text] [Related]  

  • 10. T cell subsets in patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ
    Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
    Scheiffarth F; Warnatz H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
    Deicher H; Fricke R; Kruli P
    Rev Clin Esp; 1970 Mar; 116(6):539-48. PubMed ID: 4996836
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of immunosuppressive drugs in rheumatic diseases.
    Steinberg AD
    Arthritis Rheum; 1973; 16(1):92-6. PubMed ID: 4540291
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive therapy. 1.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
    [No Abstract]   [Full Text] [Related]  

  • 17. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy of collagen diseases. Case report].
    Miti L; Massei V; Sanguinetti CM
    Minerva Med; 1974 Mar; 65(24):1310-4. PubMed ID: 4831470
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive therapy in systemic lupus erythematosus.
    Russell AS; Bretscher PA
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.